Cann Global Ltd.

• Queensland Bauxite meldet Namensänderung

  Queensland Bauxite Ltd. gab vor kurzem bekannt, dass es eine Namensänderung durchführen wird. Dabei wird sich der Name des Unternehmens zu Cann Global Limited ändern. Die Namensänderung soll den Charakter und das Ausmaß der Aktivitäten von Cann Global repräsentieren; so auch das Unternehmensgeschäft mit medizinischem Cannabis und Hanf. Im Rahmen dieser Änderung wird sich zudem das Tickersymbol von QBL zu CGB ändern.

  weiterlesen

  25.01.2019

  von Redaktion

weitere Meldungen

• Cann Global Limited: Quarterly Activities and Cashflow Report

  Cann Global submits the following Activities report and Quarterly Cash Flow Statement for the quarter ending 30 June 2020 . Key highlights: Cann Global continued to drive sales throughout the quarter resulting in cash receipts from customers of $333k up 54.6% on the prior corresponding period, but lower than the prior quarter due to shipping delays and therefore delayed payment on contracted sales. Accrued revenue [...]

  weiterlesen

  03.08.2020

  von ABN Newswire
• Cann Global Limited: Entitlement Issue Update and Shortfall Notification

  Cann Global Ltd. is pleased to confirm that the 1 for 4 renounceable entitlement offer announced on 3 July 2020 , closed on Thursday 23 July 2020. Under the Entitlement Offer, 847.5 million fully paid ordinary shares were offered to Eligible Shareholders at an issue price of $0.005. All New Shares to be issued under the Entitlement Offer will rank equally in all respects with the existing fully paid ordinary shares [...]

  weiterlesen

  28.07.2020

  von ABN Newswire
• Cann Global Limited: Rights Issue Update

  Cann Global confirms that its Directors and largest shareholders intend to participate in the rights issues announced on 3 July 2020. The announcement included a 1 for 4 pro-rata non-renounceable Entitlement Offer for eligible shareholders of fully paid ordinary shares on the basis of 1 New Share for every 4 existing shares held at the record date of 9 July 2020, together with 1 for 2 free attaching options. Eligible [...]

  weiterlesen

  11.07.2020

  von ABN Newswire
• Cann Global Limited: Research Results Lead to Broader Auto-immune Research

  On the 26th of February 2018, Cann Global's medical Cannabis research division, Medical Cannabis Research Group Pty Ltd entered into a research agreement with Professor David Meiri and his team at the Technion, Israel's renowned university, to research the possibility of the use of cannabis in the treatment of autoimmune disease, specifically multiple sclerosis. See the following link to the announcement released by [...]

  weiterlesen

  15.06.2020

  von ABN Newswire
• Cann Global Limited: Cann Global Asia Update

  The Board of Cann Global wishes to update our shareholders on the operations of its 55% owned subsidiary Cann Global Asia Pty Ltd, and its activities in Laos PDR. As previously advised in our last quarterly report, as part of the subcontracting agreement with SUN, CGA's cultivation team was due to arrive in Laos on 1st April 2020 to work on the projects. Due to the Covid-19 pandemic, the Laos border was closed on [...]

  weiterlesen

  15.06.2020

  von ABN Newswire

weitere engl. Meldungen